In addition, industry sponsored educational forums over meals and social activities will highlight the utility and appropriate utilization of the various products and devices commonly employed in the treatment of CLI.
Improved appreciation and understanding of peripheral arterial disease in general and critical limb ischemia more particularly has been fostered by and has driven developments in novel techniques and technology required to treat the heterogeneous anatomic and therapeutic challenges posed by this disease.
The affected patient population tends to be uniquely sick, afflicted with multiple comorbidities and at risk for severe adverse outcomes. Even so, conventional approaches involving incomplete or indirect revascularization, failure to provide timely, thorough preoperative non-invasive or angiographic evaluation and primary amputation are still widely seen in practice.
Systematic application of new diagnostic and interventional techniques, new concepts in wound care and an expanded palette of wound care products have yielded significant improvements in amputation free survival and increased patient and provider satisfaction. Despite clear progress slow rates of adoption and inconsistent utilization of endovascular approaches to limb preservation have retarded the decline in major amputation rates in many areas. We can do better!
Who Should Attend?
- Vascular and endovascular specialists,
- Vascular and general surgeons
- Interventional cardiologists
- Interventional radiologists
- Wound care specialists and diabetologists
- Primary care providers
- Ancillary professionals working in the interventional suite
Speakers: Lawrence Garcia, MD, Greg Landry, MD
Physician - Early Registration - until 4/4: USD 595.0,
Physician - Late Registration - after 4/4: USD 695.0,
Non-Physician / Fellows / Residents - Early Registration - until 4/4: USD 295.0,
Non-Physician / Fellows / Residents - Late Registration - after 4/4: USD 395.0,
Students - Early Registration - until 4/4: USD 100.0,
Students - Late Registration - after 4/4: USD 100.0